Prot# P05216: A Phase 3, Safety and Efficacy Study of Boceprevir in Previously Untreated Subjects With Chronic Hepatitis C Genotype 1

Project: Research project

Project Details

StatusFinished
Effective start/end date9/29/089/29/11

Funding

  • Schering-Plough Research Institute (P05216)